029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
DCO8010中、晚期结肠癌组织芯片,附病理分级、TNM和临床分期,80例/80点
Zoom
点 数80例 数80
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:DCO8010
 
中、晚期结肠癌组织微阵列芯片,含腺癌80例,其中中期45例,晚期35例,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Col
-Colon
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
Malignant (IIIC)
 
Malignant (IV)
TISSUE  ARRAYS DCO8010
1
2
3
4
5
6
7
8
9
10
A
COL
COL
COL
COL
COL
COL
COL
COL
COL
COL
B
COL
COL
COL
COL
COL
COL
COL
COL
COL
COL
C
COL
COL
COL
COL
COL
COL
COL
COL
COL
COL
D
COL
COL
COL
COL
COL
COL
COL
COL
COL
COL
E
COL
COL
COL
COL
COL
COL
COL
COL
COL
COL
F
COL
COL
COL
COL
COL
COL
COL
COL
COL
COL
G
COL
COL
COL
COL
COL
COL
COL
COL
COL
COL
H
COL
COL
COL
COL
COL
COL
COL
COL
COL
COL
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1177MColonAdenocarcinoma1T3N0M0IIAMalignant5*4N
A2259MColonAdenocarcinoma1T3N0M0IIAMalignant9.0N
A3358MColonAdenocarcinoma1T3N0M0IIAMalignant6.0*3.8*1.5N
A4460MColonAdenocarcinoma1--2T3N0M0IIAMalignant*N
A5573MColonAdenocarcinoma (sparse)2T3N0M0IIAMalignant4.5*4.5*0.5N
A6666MColonAdenocarcinoma (mucosa)*T3N0M0IIAMalignant4.5*4.0*0.5N
A7772MColonAdenocarcinoma2T3N0M0IIAMalignant*N
A8848MColonAdenocarcinoma with necrosis2T3N0M0IIAMalignant*N
A9965FColonAdenocarcinoma2T3N0M0IIAMalignant*N
A101033MColonAdenocarcinoma2T3N0M0IIAMalignant*N
B11152MColonAdenocarcinoma (necrosis)*T3N0M0IIAMalignant*N
B21239FColonAdenocarcinoma2T3N0M0IIAMalignant*N
B31369MColonAdenocarcinoma*T3N0M0IIAMalignant*N
B41464MColonAdenocarcinoma*T3N0M0IIAMalignant*N
B51572FColonAdenocarcinoma2T3N0M0IIAMalignant*N
B61645MColonAdenocarcinoma2T3N0M0IIAMalignant*N
B71756FColonAdenocarcinoma2T3N0M0IIAMalignant*N
B81858FColonAdenocarcinoma (interstitial)*T3N0M0IIAMalignant*N
B91945FColonAdenocarcinoma2T3N0M0IIAMalignant*N
B102065FColonAdenocarcinoma2T3N0M0IIAMalignant4*3.0*0.5N
C12169MColonAdenocarcinoma2T3N0M0IIAMalignant4.5*3.5*0.5N
C22256MColonAdenocarcinoma2T3N0M0IIAMalignant6*4*5N
C32354MColonAdenocarcinoma2T3N0M0IIAMalignant4.5*3.5*0.5N
C42466MColonAdenocarcinoma2T3N0M0IIAMalignant5.0*4.5*0.5N
C52548FColonAdenocarcinoma2T3N0M0IIAMalignant*N
C62661MColonAdenocarcinoma2T3N0M0IIAMalignant4.0*4.0*0.5N
C72761MColonAdenocarcinoma2T3N0M0IIAMalignant4.5*4.0*0.5N
C82863FColonAdenocarcinoma with necrosis2T3N0M0IIAMalignant4.5*4.0*0.5N
C92956MColonAdenocarcinoma2T3N0M0IIAMalignant4*3*1.0N
C103070MColonAdenocarcinoma (part mucinous adenocarcinoma)2T3N0M0IIAMalignant5.0*4.5*1.0N
D13169MColonAdenocarcinoma2T3N0M0IIAMalignant*N
D23263MColonAdenocarcinoma2T3N0M0IIAMalignant6*6*5cmN
D33360FColonAdenocarcinoma2T3N0M0IIAMalignant*N
D43472MColonAdenocarcinoma2T3N0M0IIAMalignant8*5*1N
D53561MColonAdenocarcinoma2T3N0M0IIAMalignant6*5.5*4.5N
D63651FColonAdenocarcinoma (part mucinous adenocarcinoma)2T3N0M0IIAMalignant6.0*6.0*1.0-1.5N
D73764FColonAdenocarcinoma2T3N0M0IIAMalignant6.0*6.0*1.5N
D83866FColonAdenocarcinoma with necrosis2T3N0M0IIAMalignant11*11*5N
D93945FColonAdenocarcinoma2T3N0M0IIAMalignant6.5*5.5*1.0N
D104040MColonAdenocarcinoma (part mucinous adenocarcinoma)2T3N0M0IIAMalignant4*3.5*1N
E14139MColonMucinous adenocarcinoma (sparse)3T3N0M0IIAMalignant6.5*4.5*1.5N
E24265MColonAdenocarcinoma2T4N0M0IIBMalignant3*3.5N
E34356MColonAdenocarcinoma2T4aN0M0IIBMalignant*N
E44471MColonMucinous adenocarcinoma (sparse)2T4aN0M0IIBMalignant*N
E54564FColonAdenocarcinoma2T4aN0M0IIBMalignant5.5*5.0*2.5N
E64661FColonAdenocarcinoma2T2N1M0IIIAMalignant5.0*4.5*0.5N
E74752MColonAdenocarcinoma (sparse)1T3N2aM0IIIBMalignant6.0*5.0*0.5N
E84846MColonAdenocarcinoma with necrosis2T3N1M0IIIBMalignant*N
E94970MColonAdenocarcinoma (part mucinous adenocarcinoma)2T3N1M0IIIBMalignant3*2.5*0.5N
E105037FColonAdenocarcinoma with necrosis2T3N1M0IIIBMalignant5*2N
F15154FColonAdenocarcinoma (sparse)2T3N1M0IIIBMalignant4*3*0.5cmN
F25244FColonAdenocarcinoma2T3N1M0IIIBMalignant4*4*1N
F35339MColonAdenocarcinoma (mucosa)2T3N1M0IIIBMalignant5.0*4.5*0.5N
F45467MColonAdenocarcinoma (mucosa)2T3N1M0IIIBMalignant3.5*3.0*0.5N
F55562MColonAdenocarcinoma2T3N1aM0IIIBMalignant3.5*3.5*0.5N
F65652MColonAdenocarcinoma (mucosa)2T3N1bM0IIIBMalignant4.5*4.0*0.5N
F75750MColonAdenocarcinoma2T3N1bM0IIIBMalignant4.5*4.0*1.0N
F85848MColonAdenocarcinoma2T3N2M0IIIBMalignant7.5*5.5*1.5N
F95967MColonAdenocarcinoma2T3N2M0IIIBMalignant6.0*6.0*1.0N
F106054MColonAdenocarcinoma2T3N2M0IIIBMalignant10*5.0*2N
G16154MColonAdenocarcinoma with necrosis (sparse)2T3N2M0IIIBMalignant5.0*5.0*1.0N
G26265MColonAdenocarcinoma2T3N2aM0IIIBMalignant*N
G36353MColonAdenocarcinoma2T3N2aM0IIIBMalignant*N
G46452MColonAdenocarcinoma (part mucinous adenocarcinoma)2T3N2aM0IIIBMalignant3*2*0.5N
G56573FColonAdenocarcinoma (sparse)2T3N2aM0IIIBMalignant3*3*0.5cmN
G66653MColonAdenocarcinoma (part mucinous adenocarcinoma)2T3N2aM0IIIBMalignant2.5*1.5*0.6N
G76749MColonAdenocarcinoma2T3N2aM0IIIBMalignant5.0*3.5*1.0N
G86863MColonAdenocarcinoma with necrosis (sparse)2T4aN1M0IIIBMalignant5.0*4.0*1.5N
G96957FColonAdenocarcinoma2T4aN1M0IIIBMalignant5*4.5*1.5N
G107060FColonAdenocarcinoma3T3N1M0IIIBMalignant5*7*5N
H17151MColonAdenocarcinoma with sparse necrosis3T3N1aM0IIIBMalignant3*3*0.5cmN
H27246MColonAdenocarcinoma3T3N2aM0IIIBMalignant*N
H37346MColonAdenocarcinoma3T3N2aM0IIIBMalignant8.5*8*4N
H47460MColonMucinous adenocarcinoma3T2N2aM0IIIBMalignant5.0*5.0*0.6N
H57565MColonAdenocarcinoma2T3N2bM0IIICMalignant5.0*4.5*1.0N
H67638MColonAdenocarcinoma2T3N2bM0IIICMalignant4*4*2N
H77758MColonAdenocarcinoma (sparse)2T3N2bM0IIICMalignant6.5*4.5*1.5N
H87862MColonAdenocarcinoma (interstitial)2T3N2bM0IIICMalignant5.0*4.5*1.0N
H97975FColonAdenocarcinoma2T4aN2bM0IIICMalignant6*5*6N
H108048FColonAdenocarcinoma2T3N0M1IVMalignant6*3.8*2.7N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情